0.9% recall 2026
Product mix-up where 0.9% Sodium Chloride Injection, USP overwrap may contain 10 mEq Potassium Chloride Injection
FDA enforcement data, made searchable
Check the record.
Keep the context.
Search recent United States drug recall enforcement records by name, brand, NDC, manufacturer, recall number, or lot and code information.
Independent tool | Data sourced from openFDA | Not an FDA service or medical advice
Search drug enforcement records
Coverage: September 23, 2024 to September 23, 2026. Dataset last checked Sep 23, 2026 UTC.
Current FDA topics
Recall pages with affected lots and sources
Server-rendered and checked against FDA sources
Dexmedetomidine HCl in 0.9% recall 2026
Presence of particulate matter identified as cellulose or stopper material
Compounded Glutathione 200 mg/mL 30 mL multidose vial; Myer’s Cocktail 30 mL multidose vial; Tri-Immune Boost 30 mL multidose vial recall 2026
Elevated Endotoxin level
Luna G3 APAP (Model LG3600) recall 2026
The firmware version, G3-2.00.76 installed on the Luna G3 APAP (Model LG3600) devices contained a firmware defect
Lipofit Extreme 2.0 Fat Burner Dietary Supplement recall 2026
Undeclared Fluoxetine and 2,4-Dinitrophenol (DNP)
0.9% recall 2026
Presence of particulate matter identified as zinc oxide.
0.9% recall 2026
Potential presence of particulate matter identified as fiberglass in the solution.
70% Dextrose recall 2026
Potential presence of particulate matter identified as stainless steel particles in the solution.
Anticoagulant recall 2026
Potential presence of particulate matter identified as fiberglass in the solution
Thyroid recall 2026
Potential for the Product to be Superpotent
Glutathione recall 2026
Elevated Endotoxin level
Excel® Lactated Ringers recall 2026
Presence of particulate matter identified primarily as cellulose cotton fibers, with individual particles also identified as cellulose wood fiber and polystyrene
Tyenne recall 2026
Due to Presence of Glass Particles
Compounded Glutathione 200 mg/mL Multi-Dose Vials recall 2026
Elevated Endotoxin level
Morphine Sulfate recall 2026
Due to a label mix-up
OPTIRAY Imaging Bulk Package (IBP) 350, 500mL in vial (Ioversol recall 2026
Presence of particulate matter comprising polyethylene and other plastic materials, stainless steel and glass
Adequan Canine recall 2026
Visible glass fiber material in the product
Papaverine recall 2026
Products were found to contain particulate matter
Cefazolin recall 2026
Particulate matter identified as cardboard was found in the solution.
Cyclophosphamide recall 2026
Particulate matter identified as steel was found in the product.
Cetirizine recall 2026
Potential cross contamination with ranitidine.
Nara Infant Formula recall 2026
Potential risk of Clostridium botulinum contamination.
Levothyroxine recall 2026
Searches for a levothyroxine recall are being driven in part by an FDA action concerning unapproved animal-derived thyroid medications, not a blanket recall of synthetic levothyroxine.
Latest records
Recently reported recalls
1,531 records in the current dataset
Fluphenazine Hydrochloride Tablets, USP, 1mg, 100-count bottles, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-255-01.
Ajanta Pharma USA Inc
Failed impurities/degradation specifications: (OOS) for Organic Impurities by HPLC (Impurity-A) during testing at the 18 months long term stability. Result: 1.1 percent. Spec: 1.0 percent.
Dextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare Corporation Deerfield, IL, 60016, Made in USA, NDC 00338-0719-06
Baxter Healthcare Corporation
Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.
MYXREDLIN, Insulin Human in 0.9% Sodium Chloride Injection, 100 units/100 mL (1 unit/mL), Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0126-12.
Baxter Healthcare Corporation
CGMP Deviations